News - Novo Nordisk

Filter

Current filters:

Novo Nordisk

Popular Filters

80 to 104 of 130 results

Novo Nordisk insulin degludec passes first regulatory hurdle in Japan

03-09-2012

Danish insulin giant Novo Nordisk (NOV: N) revealed on Friday that its ultra-long-acting insulin degludec…

Asia-PacificDegludecDiabetesNovo NordiskPharmaceuticalRegulation

Novo Nordisk ups forecast on strong diabetes drug sales

09-08-2012

Denmark's Novo Nordisk, the world's largest insulin producer, this morning posted financial results for…

DiabetesFinancialNovo NordiskPharmaceuticalResearch

FDA further delays Novo Nordisk's ultra long-acting insulin products Tresiba and Ryzodeg

19-07-2012

Denmark's Novo Nordisk (NOV: N), the world's largest insulin maker, says that the US Food and Drug Administration…

DiabetesNorth AmericaNovo NordiskPharmaceuticalRegulationRyzodegTresiba

Novo Nordisk and AstraZeneca among firms to invest in Russian pharma hub

11-07-2012

In Russia, the Kaluga government plans to establish a pharmaceutical manufacturing hub in the region…

AstraZenecaEuropeFinancialMarkets & MarketingMenariniNovo NordiskPharmaceuticalSTADA Arzneimittel

Novo Nordisk links with JDRF on type 1 diabetes R&D; type 2 study results

14-06-2012

Danish insulin giant Novo Nordisk (NOV: N) is partnering with the US charitable organization JDRF to…

DiabetesHealthcareNovo NordiskPharmaceuticalResearch

Highlights of American Diabetes Association meeting

11-06-2012

The weekend saw a flood of new data on diabetes drug candidates and currently approved treatments presented…

Boehringer IngelheimDegludecDiabetesEli LillyempagliflozinLyxumiaNovo NordiskPharmaceuticalResearchSanofiTradjentaVictoza

US FDA delays approval of Novo Nordisk's ultra-long acting insulins

08-06-2012

The US Food and Drug Administration has extended the regulatory review period for the ultra-long-acting…

DegludecDegludecPlusDiabetesNorth AmericaNovo NordiskPharmaceuticalRegulation

FDA expands Levemir use to young children; negative on tafamidis

23-05-2012

Denmark-based global insulin giant Novo Nordisk (NOV: N) says that the US Food and Drug Administration…

DiabetesLevemirNorth AmericaNovo NordiskPfizerPharmaceuticalRare diseasesRegulationtafamidisVyndaqel

Novo Nordisk to acquire Taiwanese osteo/RA technology

17-05-2012

Danish insulin giant Novo Nordisk (NOV: N) has acquired rights to technology developed by a southern…

Anti-Arthritics/RheumaticsLicensingNovo NordiskPharmaceuticalResearch

Exec appointments at Novo Nordisk and Teva

09-05-2012

Danish insulin giant Novo Nordisk (NOV: N) says that former Pfizer executive Robert Clark will be joining…

GenericsManagementNovo NordiskPharmaceuticalTeva Pharmaceutical Industries

New Zealand considers listing of NovoMix 30 and NovoSeven RT and amendment for Glucagen Hypokit

02-05-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, is seeking feedback on a proposal to fund…

Asia-PacificDiabetesGlucaGenNovo NordiskNovoMixNovoSevenPharmaceuticalPricingRegulation

Novo Nordisk in-licenses drug delivery technology from Caisson

01-05-2012

Danish insulin giant Novo Nordisk (NVO: N) has entered into a development and license agreement with…

Caisson BiotechHeparinexLicensingNovo NordiskPharmaceutical

Novo Nordisk starts year with 15% net profits hike

30-04-2012

Danish insulin giant Novo Nordisk (NOV: N) reported first-quarter 2012 results last Friday, with a 13%…

DegludecDiabetesFinancialNovo NordiskPharmaceuticalRyzodegTresiba

Novo Nordisk collaborates with Oxford University on RA and other inflammatory diseases research

25-04-2012

Departing from its core competence, diabetes, Danish insulin giant Novo Nordisk (NOV: N) and the Kennedy…

Anti-Arthritics/RheumaticsInflammatory diseasesNovo NordiskPharmaceuticalResearch

Positive Ph III results for Novo Nordisk's degludec; US advocacy calls for Victoza's withdrawal

23-04-2012

Danish diabetes specialist Novo Nordisk (NOV: N) says that its investigational ultra-long-acting insulin…

DegludecDiabetesNorth AmericaNovo NordiskPharmaceuticalRegulationResearchVictoza

Ground-breaking on new Novo Nordisk plant in Russia

17-04-2012

Danish insulin giant Novo Nordisk (NOV: N) broke ground yesterday on a new $100 million plant in Russia…

EuropeFinancialInsulinMarkets & MarketingNovo NordiskPharmaceutical

Novo Nordisk tests a new business model to improve insulin access in Kenya

15-04-2012

As part of an official Danish state visit to Kenya, global insulin giant Novo Nordisk (NOV: N) last week…

DiabetesInsulinMarkets & MarketingNovo NordiskPharmaceuticalPricingRest of the World

Victoza US label update includes superior efficacy over Januvia, says Novo Nordisk

10-04-2012

The US Food and Drug Administration has approved an update to the product label for Victoza (liraglutide…

DiabetesJanuviaLevemirMerck & CoNorth AmericaNovo NordiskPharmaceuticalRegulationResearchVictoza

FDA OKs pregnancy use of Novo Nordisk diabetes therapy Levemir

02-04-2012

The US Food and Drug Administration has approved Levemir (insulin detemir [rDNA origin] injection), from…

DiabetesLevemirNorth AmericaNovo NordiskPharmaceuticalRegulation

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Victoza sales boost Novo Nordisk

03-02-2012

Danish insulin giant Novo Nordisk (NVO: N) yesterday reported full-year 2011 sales of 66.35 billion Danish…

DiabetesFinancialNovo NordiskPharmaceuticalVictoza

Novo Nordisk opens type 1 diabetes R&D center in Seattle

24-01-2012

Danish insulin giant Novo Nordisk (NVO: N) said this morning that it will establish a type 1 diabetes…

DiabetesNovo NordiskPharmaceuticalResearch

80 to 104 of 130 results

Back to top